BSX - BOSTON SCIENTIFIC CORP
This page shows which of the focused investors we track hold BSX and how their positions changed, so you can see how much conviction the group has in the stock.
In Q1 2026 it was held by 6 managers with an aggregate reported value of $375.15M, which is 0.03% of the combined portfolio.
As of Q1 2026, 6 tracked institutional managers held BSX (BOSTON SCIENTIFIC CORP) with an aggregate reported value of $375.15M — 0.03% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades BSX — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q1 2026
- Ticker
- BSX
13F data is delayed and excludes shorts/non-13F assets.
Long holders
| 1 | Lee Ainslie - Maverick Capital | 3.06% | Add +42.5% | 4,195,089 | $263.24M |
| 2 | Polen Capital Management - Polen Capital Management | 0.25% | Reduce -85.6% | 579,739 | $36.38M |
| 3 | Stephen Mandel - Lone Pine Capital | 0.05% | Reduce -48.1% | 104,655 | $6.57M |
| 4 | Dodge & Cox - Dodge & Cox | 0.00% | - | 88,885 | $5.58M |
| 5 | Mairs & Power Growth Fund - Mairs & Power Growth Fund | 0.01% | - | 10,176 | $638.54K |
Call holders — bullish via leverage
1 manager holds call options on BSX — a right to buy at strike. Notional value, not premium.
| 1 | Lee Ainslie - Maverick Capital | New | 1,000,000 | $62.75M |
Loading holder history for BSX…